A. N. Ishmukhametova

A. N. Ishmukhametova

Auto-generated profile, based on publicly available information

A. N. Ishmukhametova

Bashkir State Medical University

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 March 2022 in Parodontologiya
Verified
Journal Article
Open access
PDF file
IUI. N. Usmanova
I. N. Usmanova
IGI. A. Galimova
I. A. Galimova
RKR. F. Khusnarizanova
R. F. Khusnarizanova
AIA. N. Ishmukhametova
A. N. Ishmukhametova
ILIrina Lakman
Irina Lakman
MMM. A. Al Mohamed
M. A. Al Mohamed
Relevance. The authors established that classical and mediated acid-related gastrointestinal disorders affect the change in microbiota and the development of mucosal disease.Purpose. The study aimed to investigate the characteristics of oral microbiota in patients with mucosal disease associated with classical and mediated acid-related gastrointestinal disorders.Materials and methods. The study included 58 patients with the oral mucosal disease associated with chronic gastritis and duodenitis, pancreatitis secondary to gallstones associated with stomach hypersecretion. The comparison group consisted of 25 subjects without oral mucosal disease, with previously diagnosed acid-related gastrointestinal disorders and eradicated Helicobacter pylori as of the clinical examination time.Results. The study detected a pH shift towards the acidic end of the scale in the oral fluid samples of subjects with oral aphthous ulcers compared to the group without oral mucosal disease (comparison group) (p < 0.001). The composition ratio of the studied microbiota from the surface of the oral aphthous ulcers in the main groups showed an increase in the number of Candida spp. by 1.7 and 3.2 times (p > 0.2), Enterobacteriaceae spp. – 1.7 and 2.6 times, (p > 0.2), Actinobacillus spp. – 1.4 and 2.0 times (p > 0.2), Staphylococcus spp. – 1.3 and 1.5 times (p > 0.2), Enterococcus spp. – 2.6 and 3.5 times (p > 0.2), and a decrease in Neisseria spp. by 1.9 and 3.1 times (p > 0.2). The studied microbiota of main group II (PSG associated with SH) demonstrated a significant increase in the above species, p < 0.05, and a significant decrease in Neisseria spp., at p<0.05.Conclusion. The studied aphthous ulcer surface microbiota, obtained from subjects with pancreatitis secondary to gallstones associated with stomach hypersecretion, revealed a significant overrepresentation of Gram +, Gram– facultatively anaerobic and opportunistic microorganisms contributing to the aggravation of the oral mucosal disease clinical features.

26 June 2024 in Parodontologiya
Verified
Journal Article
Open access
PDF file
VSV. O. Senina
V. O. Senina
IUI. N. Usmanova
I. N. Usmanova
ILIrina Lakman
Irina Lakman
LGL. P. Gerasimova
L. P. Gerasimova
МTМ. М. Tuigunov
М. М. Tuigunov
LKL. I. Kuznetsova
L. I. Kuznetsova
Relevance. The metabolic syndrome (MS) and type 2 diabetes mellitus (T2DM) are significant concerns in modern medicine due to their high prevalence in the general population and their crucial role in the development and progression of inflammatory periodontal diseases.Purpose. To investigate the association between periodontal diseases and the manifestations of metabolic syndrome and type 2 diabetes mellitus (T2DM).Materials and methods. The metabolic syndrome (MS) and type 2 diabetes mellitus (T2DM) are significant concerns in modern medicine due to their high prevalence in the general population and their crucial role in the development and progression of inflammatory periodontal diseases.Results. Out of 71 analysed sources, 39.1% of the studies discussed the prevalence of these metabolic diseases. In the majority of the studies (50%), the relationship between periodontal pathology and metabolic diseases related to insulin resistance and T2DM, glycaemia levels, dyslipidaemia, and fat tissue metabolism was examined. In 49.3% of the reviewed publications, data on the state of the subgingival microbiota, gingival sulcus, and saliva were presented.Conclusion. The analysis of contemporary literature sources revealed a broad interaction between metabolic diseases and periodontal pathology, highlighting their shared pathogenetic processes and providing data on glycaemic control, the condition of the oral fluid microbiota, and periodontal pockets.

21 March 2025 in Эндодонтия Today
Verified
Journal Article
Open access
PDF file
IUI. N. Usmanova
I. N. Usmanova
RYR. D. Yunusova
R. D. Yunusova
ILIrina Lakman
Irina Lakman
LGL. P. Gerasimova
L. P. Gerasimova
AIA. N. Ishmukhametova
A. N. Ishmukhametova
ESE. Yu. Startseva
E. Yu. Startseva
INTRODUCTION. The manifestations of Crohn’s disease (CD) and ulcerative colitis (UC) in the oral cavity include both nonspecific lesions and specific lesions directly associated with intestinal inflammation. Oral lesions that remain undiagnosed may subsequently be difficult to manage with therapeutic and preventive measures.AIM. To evaluate the developed diagnostic algorithm for oral mucosal pathology in patients with CD and UC.MATERIALS AND METHODS. The comprehensive clinical and dental examination included an assessment of complaints, medical history, findings from an objective examination, and laboratory investigations.RESULTS. This retrospective, multicenter study included young adults with CD and UC who were under regular medical supervision in gastroenterology departments and adhered to general treatment protocols. Clinical manifestations of lip vermilion pathology were observed in 51.43% and 42.85% of patients with CD and UC, respectively (p < 0.01), including glossodynia in 31.43% (p < 0.01) and 17.15% (p < 0.05) of cases. The main complaints of patients with diagnosed oral mucosal pathology were unpleasant sensations in the form of soreness and pain when consuming irritant foods in 100% and 65.71% of cases, respectively; discomfort during speech in 31.43% and 25.71% of cases; and dry mouth in 51.43% and 25.71% of cases. Burning sensation in the oral cavity was reported in 31.43% and 17.15% of patients.CONCLUSIONS. The correlation between clinical manifestations of oral mucosal pathology and laboratory findings necessitates biochemical monitoring of reduced vitamin B6 and B12 levels in the blood. Deficiency of these vitamins was observed in 42.9% and 28.57% of patients with CD and in 34.4% and 20.0% of patients with UC, justifying the diagnosis of desquamative glossitis (KACD = 0.73 and KAUC = 0.64). The diagnosis of fissured tongue was established in 42.9% and 28.57% of CD patients and in 14.3% and 8.6% of UC patients (KACD = 1.0, KAUC = 0.64). In CD patients in remission with vitamin B12 deficiency, the relative risks for the development of aphthous stomatitis, fissured tongue, and burning mouth syndrome with glossodynia were OR = 7.1 (CI: 1.2–41.0), OR = 11.5 (CI: 1.7–77.2), and OR = 29.3 (CI: 4.1–200.0), respectively. In the same group, vitamin B6 deficiency increased the risk of fissured tongue (OR = 12.7, CI: 1.3–121.4) and burning mouth syndrome with glossodynia (OR = 13.5, CI: 2.3–80.8). In UC patients, deficiencies in vitamin B12 and B6 were criteria for the development of recurrent aphthous stomatitis (OR = 19.2, CI: 1.9–196.5 and OR = 9.2, CI: 1.4–59.6, respectively), fissured tongue (OR = 13.5, CI: 1.6–115.9 and OR = 9.8, CI: 1.2–77.7, respectively), and burning mouth syndrome with glossodynia (OR = 8.7, CI: 1.02–63.8 and OR = 17.3, CI: 2.2–138.2, respectively). Low hemoglobin levels in CD patients increased the risk of geographic glossitis (OR = 4.9, CI: 1.01–29.4) and the manifestation of burning mouth syndrome with glossodynia (OR = 6.0, CI: 1.2–29.7). Interdisciplinary collaboration between dentists, gastroenterologists, general practitioners, and neurologists is essential for the early diagnosis of lip vermilion and oral mucosal pathology in patients with CD and UC manifestations.

26 June 2025 in Parodontologiya
Verified
Journal Article
Open access
PDF file
IUI. N. Usmanova
I. N. Usmanova
VSV. O. Seninа
V. O. Seninа
ILIrina Lakman
Irina Lakman
LGL. P. Gerasimova
L. P. Gerasimova
DADiana Avzaletdinova
Diana Avzaletdinova
LKL. I. Kuznetsova
L. I. Kuznetsova
Relevance. This study presents results of a comprehensive dental assessment in patients with carious lesions of dental hard tissues associated with metabolic syndrome (MetS) and type 2 diabetes mellitus (T2DM).Objective. To assess dental caries risk based on glycemic status in patients with components of metabolic syndrome.Materials and methods. The dental examination included evaluation of caries experience using the DMFT index and assessment of caries prevalence. Salivary pH was measured using litmus paper. Glycemic status was evaluated using fasting and 2-hour postprandial venous blood glucose measurements. Glycated hemoglobin (HbA1c) levels were determined using high-performance liquid chromatography.Results. Dental caries risk correlated with glucose levels in both venous blood and saliva. Patients with metabolic syndrome and impaired glucose metabolism showed a moderate positive correlation (Spearman’s ρ = 0.49 and ρ = 0.55, respectively), while T2DM patients demonstrated a strong correlation (ρ = 0.62 and ρ = 0.69, respectively). HbA1c levels were significantly associated with caries experience: ρ = 0.46 in MetS patients without glycemic dysregulation, ρ = 0.51 in those with impaired glucose metabolism, and ρ = 0.75 in the T2DM group. The caries risk assessment method showed 77% sensitivity and specificity in T2DM patients, and 50% in patients with MetS components.Conclusion. Patients with T2DM have a significantly higher risk of dental caries, which correlates strongly with blood and salivary glucose levels. Elevated HbA1c levels are associated with more carious teeth, indicating the need for extended dental treatment in T2DM patients. These findings highlight the importance of educating poorly controlled T2DM patients about their increased caries risk. Additionally, dental visits may provide a cost-effective opportunity for early screening of T2DM and metabolic syndrome components.

23 April 2024 in Russian Journal of Operative Surgery and Clinical Anatomy
Verified
Journal Article
Closed access
VSV.O. Senina
V.O. Senina
IUI.N. Usmanova
I.N. Usmanova
ILIrina Lakman
Irina Lakman
LGL.P. Gerasimova
L.P. Gerasimova
AIA.N. Ishmukhametova
A.N. Ishmukhametova
YVYuriy Vasil'ev
Yuriy Vasil'ev
Pathology of the red border of the lips and the oral mucosa itself is very often associated with metabolic syndrome (MS) and diabetes mellitus (DM). Objective. The aim of this work is to study the relationship of the components of metabolic syndrome with pathology of the red border of the lips and the oral mucosa. Material and methods. An observational complex dental survey of 105 patients with MS was conducted. The presence of xerostomia was confirmed by the sialometry method, the assessment of burning mouth syndrome was carried out based on the DN4 questionnaire. Three groups of patients were distinguished among them: patients with type 2 diabetes mellitus (n=52), with metabolic syndrome caused by carbohydrate metabolism disorder (n=26), with metabolic syndrome without disorders (n=27). Results. As a result, it was revealed that glossitis, candidiasis, burning mouth syndrome, xerostomia, and lichen planus prevail in patients with MS caused by carbohydrate metabolism disorder compared to the group with MS without glycemic control disorder. In terms of the frequency of oral mucosa and red border pathologies, the group of patients with MS with carbohydrate metabolism disorder approaches the frequency of their occurrence in patients with type 2 diabetes mellitus. Conclusion. The revealed changes in the dental status in the form of the presence of pathology of the red border of the lips and the oral mucosa must be taken into account when developing and planning high-quality diagnostic measures, which will be the criteria for developing further treatment and preventive measures, together with an endocrinologist, therapist and neurologist.

13 March 2025 in Russian Journal of Pain
Verified
Journal Article
Closed access
RYR.D. Yunusova
R.D. Yunusova
IUI.N. Usmanova
I.N. Usmanova
ILIrina Lakman
Irina Lakman
AAA.P. Akopyan
A.P. Akopyan
AIA.N. Ishmukhametova
A.N. Ishmukhametova
EGE.A. Gaisina
E.A. Gaisina
Objective. To analyze intensity, time and pathophysiological type of somatic, orofacial and neuropathic pain symptoms in patients with Crohn’s disease (CD) and ulcerative colitis (UC). Material and methods. An observational prospective study included 70 patients with CD and UC in remission. We analyzed status of oral mucosa and vermilion border. Somatic, orofacial and neuropathic pain was assessed using visual analogue scale (VAS) and Douleur Neuropathique 4 (DN4) questionnaire. To estimate the symptoms of gastric and intestinal dyspepsia, we used a validated 7x7 questionnaire. Results. Severity of somatic abdominal pain was significantly higher patients with CD (p<0.05). On the background of extraintestinal manifestations of inflammatory bowel diseases, intensity of nociceptive diffuse pain in the abdomen with unclear localization and pain-like distension in the stomach after eating was significantly higher in patients with CD (p<0.1). Incidence of neuropathic pain was similar in patients with CD and UC (p=0.037). Scores of orofacial pain following lesions vermilion border and oral mucosa were higher in patients with CD during intake of irritating food and personal hygiene (p<0.05). Mean intensity of orofacial pain corresponds to moderate pain regardless of manifestations of inflammatory bowel diseases (p=0.171). Neuropathic component of pain in these patients was diagnosed in 24.29% of cases. Conclusion. Somatic, orofacial and visceral pain occurs in all patients with Crohn’s disease and ulcerative colitis. Signs of neuropathic pain are observed in 24.29% of cases. These data may be crucial for effective therapeutic approach to these patients.